Il-17a G197a Gene Polymorphism Contributes To Susceptibility For Liver Cirrhosis Development From Patients With Chronic Hepatitis B Infection In Chinese Population

Jian Ge,Yuan-Zi Yu,Tao Li,Zhao-Yang Guo,Hao Wu,Shao-Can Tang,Xin-Guang Liu,Qiang Zhu
2015-01-01
Abstract:Background: IL-17A G197A and IL-17F A7488G gene polymorphisms are found to be associated with the risk of several diseases, however few studies have focused on their correlation with risk of liver cirrhosis (LC). Aims: The aim of this study was to assess the impact of IL-17A G197A and IL-17F A7488G gene polymorphisms on development of LC from chronic hepatitis B (CHB) in Chinese patients. Methods: A total of 163 HBV-related LC patients and 168 CHB patients were enrolled in the present study. IL-17A and IL-17F gene polymorphisms were analyzed using a polymerase chain reaction (PCR) restriction fragment length polymorphism assay (PCR-RFLP). Results: Frequencies of IL-17A G197A genotype AA and allele A were significantly higher in LC patients compared with that in CHB patients (AA 42.33% vs 27.98%, P = 0.032; A 56.34% vs 46.15%, P=0.011, respectively); While no significant difference in frequencies of genotypes and alleles of IL-17F A7488G was found between the two groups. The AA genotype of IL-17A G197A significantly increased LC risk (OR 4.186, 95% CI: 1.479-11.844), while A allele carriers were also associated with an increased LC risk (OR 1.856, 95% CI: 1.161-2.967). Conclusion: IL-17A G197A is a candidate gene that confers the genetic susceptibility for LC development from CHB in Chinese population.
What problem does this paper attempt to address?